Machine Learning Model Shows Promise for Improving Metanephrine Testing Accuracy Common HbA1c Assay May Miss Diabetes in People with Sickle Cell Trait Blood Protein Panel Predicts Timing of ALS Symptom Onset Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis Circular RNAs Enable Noninvasive Cancer Detection and Risk Assessment Polygenic Risk Score Test Estimates Inherited Coronary Artery Disease Risk AI Tool Improves Long-Read Detection of Cancer Mutations FDA Clears Molecular Test for Bacterial Vaginosis and Candida Vaginitis Genomic Fingerprints Reveal Early Chemotherapy Resistance in Childhood Cancer Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma New Marker Helps Detect Aggressive Multiple Myeloma Earlier New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer AI Decision Support System Guides Treatment Selection for Complex Blood Cancers Blood Test Helps Predict Short-Term Mortality After Severe Heart Attack Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis Ultrasensitive Blood Test Detects Sjgrens Signature Years Before Diagnosis New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients Cell-Free Assay Detects Functional IgE for Food Allergy Diagnosis Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19 High-Throughput Automated Platform to Advance Latent Tuberculosis Testing Expanded Diagnostics and Therapies Target Rising Gonorrhea Resistance New Rapid Ebola Antigen Test Detects Infection at Point of Care Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections Training Device Improves Accuracy of Pooled Molecular Diagnostics New CE-Certified Software Advances Whole-Genome Cancer Testing National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines Agentic AI Platform Supports Genomic Decision-Making in Oncology New Collaboration Integrates Low-Code Automation into Laboratory Platform LumiQuick Advances Oxidative Stress Research with Expanded AOXRE Portfolio Collaboration Advances Sputum-Based Diagnostics for Asthma and COPD Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal AI-Powered Genome Mapping Reveals New Layer of Alzheimers Disease Biology Genetic Variations Reveal Mechanisms Behind Sudden Cardiac Death Risk Immune Biomarkers Support Early Risk Stratification in Oral Precancer Global Genetic Map Identifies Regional Parkinsons Variants to Support Diagnostics Breakthrough Genetic Map Advances Understanding of Bone Disorders AI Pathology Tool Stratifies Rectal Cancer to Guide Chemoradiotherapy PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers AI Digital Pathology Platform Standardizes IHC Scoring in Breast Cancer Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity Machine Learning Model Shows Promise for Improving Metanephrine Testing Accuracy Common HbA1c Assay May Miss Diabetes in People with Sickle Cell Trait Blood Protein Panel Predicts Timing of ALS Symptom Onset Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers Preoperative Blood Test Predicts Colorectal Cancer Recurrence and Metastasis Circular RNAs Enable Noninvasive Cancer Detection and Risk Assessment Polygenic Risk Score Test Estimates Inherited Coronary Artery Disease Risk AI Tool Improves Long-Read Detection of Cancer Mutations FDA Clears Molecular Test for Bacterial Vaginosis and Candida Vaginitis Genomic Fingerprints Reveal Early Chemotherapy Resistance in Childhood Cancer Spectral Flow Cytometry Assay Enhances MRD Detection in Multiple Myeloma New Marker Helps Detect Aggressive Multiple Myeloma Earlier New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer AI Decision Support System Guides Treatment Selection for Complex Blood Cancers Blood Test Helps Predict Short-Term Mortality After Severe Heart Attack Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis Ultrasensitive Blood Test Detects Sjgrens Signature Years Before Diagnosis New Assays Expand Cytokine Testing for Transplant and Immunocompromised Patients Cell-Free Assay Detects Functional IgE for Food Allergy Diagnosis Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19 High-Throughput Automated Platform to Advance Latent Tuberculosis Testing Expanded Diagnostics and Therapies Target Rising Gonorrhea Resistance New Rapid Ebola Antigen Test Detects Infection at Point of Care Syndromic GI Panel Detects Cyclospora for Rapid Case Confirmation Rapid Panel Identifies Gram-Negative Pathogens and Resistance Markers in Bloodstream Infections Training Device Improves Accuracy of Pooled Molecular Diagnostics New CE-Certified Software Advances Whole-Genome Cancer Testing National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines Agentic AI Platform Supports Genomic Decision-Making in Oncology New Collaboration Integrates Low-Code Automation into Laboratory Platform LumiQuick Advances Oxidative Stress Research with Expanded AOXRE Portfolio Collaboration Advances Sputum-Based Diagnostics for Asthma and COPD Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015 Portable Molecular Diagnostics System Unveiled At 2015 AACC Expanded Steroid Control Launched at the 2015 AACC Annual Meeting Eco-Friendly Immunoassay Reagents Featured at AACC 2015 Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting Derived Exosomal Protein Biomarkers in Alzheimers Disease Diagnosis New Biochip Array Developed for ApoE4 Classification Cell-Free DNA Identifies Liver Transplant Patients with Acute Rejection New Method Tested for Early Diagnosis Pediatric Diabetic Nephropathy FDA-Cleared Automated Cell Counter for CSF Launched at AACC 2016 Mesa Biotech Showcases PCR Testing Platform at Clinical Expo Abbott Diagnostics Displays Alinity Family of Systems Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC Sysmex Highlights Innovations in Flow Cytometry, Urinalysis and Hematology Ortho Clinical Diagnostics Unveils Next-Gen Analyzer at Lab Show AI-Powered Genome Mapping Reveals New Layer of Alzheimers Disease Biology Genetic Variations Reveal Mechanisms Behind Sudden Cardiac Death Risk Immune Biomarkers Support Early Risk Stratification in Oral Precancer Global Genetic Map Identifies Regional Parkinsons Variants to Support Diagnostics Breakthrough Genetic Map Advances Understanding of Bone Disorders All Virtual 2020 AACC Uses Artificial Intelligence to Connect Exhibitors and Attendees Greiner Bio-One Showcases VACUETTE Virus Stabilization Tube for Transport and Storage of COVID-19 Swab Samples Stago Diagnostics Transforms Hemostasis with Innovations at AACC 2020 Virtual Event Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event Seegene Highlights High-Throughput, Single Tube 8-Plex RT-PCR Test for Flu A, Flu B, RSV and COVID-19 with Dual Internal Controls New Test that Measures Antibodies in Girls Who Have Received HPV Vaccine Presented at AACC 2021 Novel Insights on COVID-19 Vaccines and Virus Evolution, AI in the Clinic, and Miniaturization of Diagnostic Platforms Explored at AACC 2021 Seegene Unveils New STARlet-AIOS All-in-One Solution for All Molecular Testing at AACC 2021 Group K Diagnostics Demonstrates KromaHealth Kit that Enables Lab-Quality Results at Point-of-Care Fluxergy Introduces First-of-Its-Kind Multi-Modal Laboratory Platform That Diagnoses COVID-19 On-Site in 60 Minutes Faster Method Diagnoses Pediatric Urinary Tract Infections Tianlong Showcases Integrated PCR Lab Solutions at AACC 2022 Cellavision Introduces New Workflow Solution for Low-Volume Hematology Labs at AACC 2022 Advanced Instruments Introduces New Automated Osmometer at AACC 2022 Innovative Smartphone and AI-Based Tests Featured at AACC 2022 Ground-Breaking Phage-Based Diagnostic Kit for Laboratory Tuberculosis Testing Presented at AACC 2023 Laboratory Experts Show How They Are Leading the Way on Global Trends Unique Competition Focuses on Using Data Science to Forecast Preanalytical Errors Best Approach to Infectious Disease Serology Testing for Laboratorians and Clinicians Discussed at AACC 2023 Breaking Research Throws Light on COVID, Flu, and RSV Co-Infections Cytovale Demonstrates 8-Minute Sepsis Diagnostic Test EKF Diagnostics Showcases Range of Diabetes and Hematology POC Devices Inpeco Launches Next-Generation Total Lab Automation System Tianlong Showcases Latest Products in Molecular Diagnostics, Biochemistry, Immunology and POC Testing Messe Dsseldorf Promotes International MEDICAlliance Portfolio at ADLM 2024 Breaking Research to Make Testing for Gynecologic Cancers More Equitable and Accurate Clinical Data on New Assay Panel Demonstrates Accurate Assessment of Pancreatic Cancer Risk AI-Powered Lyme Disease Diagnostic Test Debuts at ADLM 2025 New Study Reveals Rapid Sepsis Test Drives 56% Boost in ED Discharges First-Ever Fingerstick Host-Response Test Rapidly Differentiates Between Bacterial and Viral Infections Kompass Diagnostics Wins 2026 ADLM Disruptive Technology Award for Rapid Multimodal Testing Platform SNIBE Showcases Total Lab Automation and Diagnostic Platforms at ADLM 2026 Seegene Dispalys Connected Molecular Diagnostic Platforms at ADLM 2026 Zybio Exhibits Range of Hematology, Immunoassay and Mass Spectrometry Systems Helena Laboratories Showcases Electrophoresis and Hemostasis Solutions AI Pathology Tool Stratifies Rectal Cancer to Guide Chemoradiotherapy PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers AI Digital Pathology Platform Standardizes IHC Scoring in Breast Cancer Digital Pathology Tool Predicts Breast Cancer Outcomes and Therapy Response AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity
Phase separation due to reduced solubility can occur under certain conditions of shipping or storage (e.g
this necessitates continued investment in both the basic biology and translation of these agents
The glycine bond acts as a passport, allowing the magnesium to be absorbed through amino acid pathways rather than competing for mineral transporters
